TrueBlue Stock Price and Value Analysis

TrueBlue (NYSE:TBI) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

  • Ticker: TBI (NYSE)
  • Current price: $11.80
  • Sector: Unknown
  • Industry: Unknown

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold TrueBlue to reach your target.

Target type

TBI Free Cash Flow Trend

Free Cash Flow trendline for TBI
Free Cash Flow trendline for TrueBlue

Hmm, we can't give any reliable projection for TrueBlue's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This stock looks overpriced.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the TBI Numbers

TBI Price
(TrueBlue stock price per share)
$11.80
[?] PE Ratio versus Sector 208% higher than other Unknown stocks
[?] PE Ratio versus Industry 27% lower than other Unknown stocks
[?] Cash Yield 16.71%
[?] Free Cash Flow Jitter 133%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 449,533 shares shorted. With 28,076,416 shares available for purchase and an average trading volume over the past 10 trading days of 448,950, it would take at least 1.0 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 12 fiscal years from 2008 to 2025 with positive net income, operating cash flow totaled $824 million against net income of $583 million, or 1.41 times. Net income was negative in 6 of the 18 years, and those years are left out of the ratio.

In 2025, net income was -$48 million and operating cash flow was -$58 million, so no ratio is shown for that year.

In 2023, capital expenditures were $31.3 million, 90.0% of operating cash flow of $34.8 million, which leaves an estimated $3.5 million after capex. Across the 16 years with reported capex, it averaged 25.1% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2008 -4.2 92.4 26.1 n/a
2009 8.8 33.6 13.2 3.82
2010 19.8 42 7 2.12
2011 30.8 30.6 9.7 0.99
2012 33.6 52.3 17.8 1.56
2013 44.9 86.1 13 1.92
2014 65.7 47.5 16.9 0.72
2015 71.2 72.1 18.4 1.01
2016 -15.3 261 29 n/a
2017 55.5 100 22 1.81
2018 65.8 126 17.1 1.91
2019 63.1 93.5 28.1 1.48
2020 -142 153 27.1 n/a
2021 61.6 20.4 35 0.33
2022 62.3 121 30.6 1.94
2023 -14.2 34.8 31.3 n/a
2024 -126 -17.1 24.2 n/a
2025 -48 -58 15.7 n/a

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2012 to 2024 with dividend or share repurchase facts, estimated free cash flow totaled $708 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In 7 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $262 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2012 37.5 n/a 4.4 4.4 11.7%
2016 242 n/a 5.7 5.7 2.4%
2017 80.3 n/a 36.7 36.7 45.7%
2018 105 n/a 34.8 34.8 33.2%
2019 70.6 n/a 38.8 38.8 55.0%
2020 128 n/a 52.3 52.3 40.9%
2021 -5.4 n/a 16.7 16.7 n/a
2022 92.9 n/a 60.9 60.9 65.6%
2023 4.3 n/a 34.2 34.2 788.3%
2024 -46.7 n/a 21.3 21.3 n/a

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $2,751 million in 2016 and $1,616 million in 2025, a compound annual growth rate of -5.7% over 9 years.

Revenue rose 3.1% from 2024 to 2025.

Our estimated free cash flow was -$85.4 million in 2025, a negative margin of 5.3% of revenue, meaning the estimate was below zero. In 2016 the estimated margin was 8.8%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2016 2,751 242 8.8%
2017 2,509 80.3 3.2%
2018 2,499 105 4.2%
2019 2,369 70.6 3.0%
2020 1,846 128 6.9%
2021 2,174 -5.4 -0.2%
2022 2,254 92.9 4.1%
2023 1,906 4.3 0.2%
2024 1,567 -46.7 -3.0%
2025 1,616 -85.4 -5.3%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $24.5 million against total liabilities of $364 million, or 6.7% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 57.0% of total assets in 2025, compared with 44.9% in 2009, an increase of 12.1 percentage points.

Stockholders equity was $275 million in 2025, compared with $285 million in 2009, a fall of 3.8%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was -18.0% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2009 518 124 233 285
2010 546 163 234 313
2011 561 109 267 294
2012 602 130 268 334
2013 719 122 326 393
2014 1,067 19.7 597 469
2015 1,259 29.8 724 536
2016 1,130 35 605 525
2017 1,109 28.8 554 555
2018 1,115 47 523 591
2019 1,136 37.6 510 626
2020 981 62.5 543 437
2021 1,033 49.9 540 493
2022 1,019 72.1 523 496
2023 899 61.9 442 458
2024 675 22.5 360 315
2025 639 24.5 364 275

Price Versus Our Estimated Value

Only 15 of the 18 fiscal years under TrueBlue's current filer show positive free cash flow.

Free cash flow is volatile from year to year, with a variability measure of 133%.

We do not estimate a fair value for TrueBlue while its free cash flow growth is not positive, so there is no value comparison here.

Dividends are not in our data for TrueBlue.

These figures are automated calculations from SEC filings and the recent price. They are not a recommendation to buy or sell. See how we estimate value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 768899.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow was negative in 3 of the 18 years we have.
  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • We have no value estimate for this stock, so no price comparison is made.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-19
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: TBI annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in TBI

Does TrueBlue have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: TBI

This example shows how we apply the Trendshare checklist to TBI: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 11.80
    • Market cap: $360M
    • EPS: -1.52
  2. Step 2 — Valuation checks

    • P/E: —
    • FCF yield: 16.7%
    • Date checked: Nov 19, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.